Grifols, S.A. reported €7.21B of revenue over the trailing twelve months, +9.4% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: €7.21B (to FY2024). Net Income: €157M, trailing twelve months to FY2024. Free Cash Flow: €670M, trailing twelve months to FY2024. Op Margin: 17%, trailing twelve months to FY2024.

GRFSGrifols, S.A.

HealthcareUSD

$7.74

$7.0052 weeks$10.19

GRFS as reported

Grifols, S.A. reported €7.21B of revenue over the trailing twelve months, +9.4% on the year before. 10 reported series are charted on this page, each one as filed.

€7.21B

Revenue, trailing twelve months · to FY2024 · +9.4% against the twelve months before

Net Income: €157M
Net Income · +271% year on year · trailing twelve months to FY2024
Free Cash Flow: €670M
Free Cash Flow · −11750% year on year · trailing twelve months to FY2024
Op Margin: 17%
Op Margin · trailing twelve months to FY2024

Every series Ryufin has for GRFS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	€7.21B	+9.4%	FY2024
Net Income	€157M	+271%	FY2024
EPS	€0.23	+283%	FY2024
Gross Margin	39%	n/a	FY2024
Op Margin	17%	n/a	FY2024
Net Margin	2.2%	n/a	FY2024
ROE	2.7%	n/a	FY2024
ROA	0.73%	n/a	FY2024
ROIC	12%	n/a	FY2024
Free Cash Flow	€670M	−11750%	FY2024